|
Q2 FY2027
As of Aug 1, 2026
|
Q1 FY2027
As of May 2, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Nov 1, 2025
|
Q2 FY2026
As of Aug 2, 2025
|
Q1 FY2026
As of May 3, 2025
|
Q4 FY2025
As of Feb 1, 2025
|
Q3 FY2025
As of Nov 2, 2024
|
Q2 FY2025
As of Aug 3, 2024
|
Q1 FY2025
As of May 4, 2024
|
Q4 FY2024
As of Feb 3, 2024
|
Q3 FY2024
As of Oct 28, 2023
|
Q2 FY2024
As of Jul 29, 2023
|
Q1 FY2024
As of Apr 29, 2023
|
Q4 FY2023
As of Jan 28, 2023
|
Q3 FY2023
As of Oct 29, 2022
|
Q2 FY2023
As of Jul 30, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash, current | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventories | ||||||||||||||||||
| Connected device costs, current | ||||||||||||||||||
| Deferred commissions, current | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Restricted cash, non-current | ||||||||||||||||||
| Long-term investments | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Connected device costs, non-current | ||||||||||||||||||
| Deferred commissions, non-current | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||
| Operating lease liabilities, current | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||
| Preferred stock, $0.0001 par value—400,000,000 shares authorized as of August 1, 2026 and January 31, 2026; zero shares issued and outstanding as of August 1, 2026 and January 31, 2026 | ||||||||||||||||||
| Common stock | ||||||||||||||||||
| Common Class A | ||||||||||||||||||
| Common Class B | ||||||||||||||||||
| Common Class C | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
